Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018214
Filing Date
2025-06-25
Accepted
2025-06-25 17:45:07
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 form4-06252025_050603.html 4  
1 form4-06252025_050603.xml 4 4545
  Complete submission text file 0001415889-25-018214.txt   6099
Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
TETLOW SHARON (Reporting) CIK: 0001328565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41608 | Film No.: 251074632

Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)